Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain mechanisms of levodopa-responsive versus levodopa-resistant resting tremor in Parkinson's disease
NL-OMON20997Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levodopa + benserazide, domperidone and Placebo-COD Research Private Ltd in Parkinson's disease (PD), sponsored by Radboud University Medical Center. Primary endpoint: Difference in tremor-related brain activity. Started Jun 2014; status: recruiting.
02
Drugs
levodopa + benserazidedomperidonePlacebo-COD Research Private Ltd
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON20997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20997.